AKT phosphorylation by AEG-1 induced enhanced cell survival and proliferation through the suppression of forkhead box O3A (FOXO3A) activity in prostate cancer and FOXO1 in breast cancer [196,197]. This evidence concerns the gene AKT1 and prostate carcinoma.